Thyroid Marker Profile
Sample Type
Recommended for
Report
Includes : Chromogranin A, Calcitonin, CEA
Overview:
Thyroid Marker Profile helps diagnose or monitor thyroid cancers. Chromogranin A, Calcitonin, and CEA (Carcinoembryonic Antigen) are all markers that may be used to help diagnose or monitor certain types of thyroid or other types of cancer. Chromogranin A and Calcitonin are both markers of neuroendocrine tumors, while CEA is a marker of various types of cancer, including colorectal cancer. These markers are typically measured through a blood test, but the interpretation of results will depend on the individual case and the context in which the test is being performed.
Associated Tests:
- Cancer marker profile – Thyroid-DTC
- Thyroid Comprehensive Profile-1
- Thyroid Comprehensive Profile-2
- Thyroid Marker Profile
- Thyroid panel-1 (T3/T4/TSH)
- Thyroid panel-2 (FT3, FT4, TSH)
- Thyroid Panel-3 (Reflex)
- Thyroid Panel-4
Price : ₹ 4,230
The Thyroid Marker Profile with Chromogranin A, Calcitonin, and CEA is typically done to help diagnose and monitor certain types of thyroid cancer. Chromogranin A and Calcitonin are markers for medullary thyroid cancer, while CEA (carcinoembryonic antigen) is a marker for other types of thyroid cancer. These markers can be measured through a blood test and can help determine the stage of the cancer and monitor the effectiveness of treatment.
The Thyroid Marker Profile with Chromogranin A, Calcitonin, and CEA is typically recommended for people who have a history of or are at risk for medullary thyroid cancer or other types of thyroid cancer. This may include people with a family history of the disease, those who have had radiation exposure to the head or neck, and those who have a goiter (an enlarged thyroid gland).
- The Thyroid Marker Profile is also recommended for people who have symptoms that suggest thyroid cancer, such as a lump in the neck, difficulty swallowing, or hoarseness.
- The Thyroid Marker Profile is done in people who have a strong suspicion of having thyroid cancer, or as a follow-up after a diagnosis to monitor the disease progression and treatment effectiveness.
This test requires a blood sample. A tourniquet (elastic) band is placed tightly on the upper arm. The patient is then asked to make a fist. This helps in the build-up of blood filling the veins. The skin is disinfected before needle insertion and the blood sample is collected in vacutainer.
- If the Chromogranin A, Calcitonin, and CEA tests are positive for thyroid cancer, it may indicate that the patient has or is at risk for medullary thyroid cancer or other types of thyroid cancer.
- Elevated levels of Chromogranin A and Calcitonin in the blood may be indicative of medullary thyroid cancer, a rare type of cancer that begins in the cells of the thyroid that produce the hormones calcitonin and chromogranin A.
- Elevated levels of CEA (carcinoembryonic antigen) in the blood may be indicative of other types of thyroid cancer, such as papillary or follicular thyroid cancer.
